Annoying tremor? Zuranolone as an oral ad... - Cure Parkinson's

Cure Parkinson's

26,582 members27,897 posts

Annoying tremor? Zuranolone as an oral adjunct to treatment of Parkinsonian tremor: A phase 2, open-label study

Farooqji profile image
4 Replies

Highlights

•Zuranolone (SAGE-217) is an investigational oral neuroactive steroid GABAA receptor positive allosteric modulator (PAM).

•Zuranolone was administered for seven days in 14 patients with PD, and reduction of tremor symptoms was assessed.

•The MDS-UPDRS Part II/III tremor score improved 40% (p < 0.0001) from baseline on Day 8.

•The motor score and non-motor and motor EDL scores (MDS-UPDRS Parts I and II, respectively) also improved at Day 8.

•No serious AEs were reported, and no patients discontinued treatment.Zuranolone

sciencedirect.com/science/a...

Written by
Farooqji profile image
Farooqji
To view profiles and participate in discussions please or .
4 Replies
healthabc profile image
healthabc

thank God! At least there's something to hope for-

sharoncrayn profile image
sharoncrayn

IQ:

RE:SAGE-217

I thought this SAGE THERA/BIOGEN drug "failed" in previous antidepressant CTs (MOUNTATIN). I don't understand the long term implications of using this drug unless it is very specific to PD, which apparently it can be.

Very small (n=14)...7 or 14 day administration test, for late stage PD...extremely positive, unfortunately no lag analysis available.

Long way to go.

Sharon

Cagey84 profile image
Cagey84 in reply tosharoncrayn

Hi Sharon - it seems there is even longer to go as SAGE-217 is no longer mentioned in the company pipeline for PD - sagerx.com/programs-researc... . The focus is now on depression. Shame.

sharoncrayn profile image
sharoncrayn in reply toCagey84

CG,

Confusing to say the least, but i thought Biogen bought the rights for $3Billion or entire company.

Besides, the case size was so small and so short, I wonder about "pygmalion" EFFECTS a la DBS, etc. outside a medical center setting. Was it for real? Was the tremor reduction "subjective". 40% is a huge reduction if baseline was significant. Not so much if #s were low to begin with. Very important.

However,

"Subject must have a diagnosis of ET, defined as bilateral postural tremor and kinetic tremor, involving hands and forearms, that is visible and persistent and the duration is >5 years prior to screening." = at least moderate PD IMO.

Sometimes it is simply a $$$ decision.

Sharon

Not what you're looking for?

You may also like...

Encouraging results from the CureParkinsons supported Phase II clinical trial of the GLP-1R agonist Liraglutide

There were 37 randomly assigned to Liraglutide & 18 on placebo (2:1); At 54 weeks, non-motor...

Palmitoylethanolamide - Luteolin: Kind of Interesting

So I was bouncing around and found this article: Palmitoylethanolamide/Luteolin as Adjuvant Therapy...

Here is a supplement, PEA, that Parkinson's News Today says works well for PWP

I've been looking at this lately and I'm wondering if some of you already know about it and/or are...
MBAnderson profile image

Efficacy of oral administration of licorice as an adjunct therapy on improving the symptoms of patients with Parkinson's disease, A randomiz

I don't have the complete paper, but this link shows a lot of it. They gave 5cc of licorice twice a...

Phase 3, the Lighthouse study, Biogen and Denali, LRRK2 inhibitor BIIB122; New clinical trial registered

New clinical trial registered: Biogen and Denaliti have initiated the 2nd late-stage study of...